A landmark study reveals that a single oral dose of baloxavir marboxil (baloxavir) significantly reduces the transmission of influenza within households, marking a major advancement in influenza ...

A landmark study published in The New England Journal of Medicine [link to the publication] reveals that a single oral dose of baloxavir marboxil (baloxavir) significantly reduces the transmission of ...

Baloxavir marboxil (baloxavir) is a polymerase acidic protein (PA) endonuclease inhibitor with clinical efficacy in the treatment of uncomplicated influenza, including in outpatients at increased risk ...

Baloxavir, compared with oseltamivir, was associated with lower health care resource utilization and costs in patients with influenza, particularly those at high risk of secondary complications.

Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease. It has shown therapeutic activity in preclinical models of influenza A and B virus infections, including strains ...

A new antiviral drug shows promise for treating acute, uncomplicated influenza — including avian and oseltamivir-resistant strains — in adults and children older than age 12 years, new research shows.

Discover comprehensive details about Baloxavir Marboxil, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...